Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting) Forecast and Future Trends 2019

The research report states that the global and China insulin market is expected to grow at a CAGR of 6.10% between 2013 and 2019 to reach US$32.2 bn by the end of 2019, from US$19.9 bn in 2012. The global and China insulin market is segmented on the basis of mode of action and source. The modes of action seen in the insulin market are rapid-acting, long-acting, short-acting, intermediate-acting, and premixed. On the other hand, the sources of insulin are human insulin and modern insulin.

Get the Sample Report of Global and China Insulin Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=259

Amongst the types of insulin, the long-lasting insulin segment is expected to grow at a CAGR of 8.70% in the forecast period. This mode of action for managing sugar levels will be popular amongst insulin-dependent diabetics, as only a small dosage is required to bring down blood glucose. Additionally, relatively relaxed regulations regarding the pricing of long-lasting insulin and availability of a wide range of products will also foster the growth of this segment in the overall insulin market.

In 2012, the rapid-acting insulin segment was at the second position in the overall market. In the same period, the premixed insulin segment held a market share of over 50% in the global and China insulin market. In the foreseeable future, intermediate-acting and short-acting insulin are expected to lose ground, as diabetics are shifting preferences and neither of these types of insulin are supported by adequate research and development channels.

Rising demand for long-acting insulin derivatives is attributed to advantages such as reduced number of doses compared to other derivatives. Moreover, strong pipeline, lack of stringent regulations on price capping and high entry barriers for biosimilar manufacturers are other important growth drivers in the market. The market for modern insulin is also expected to increase during the forecast period from 2013 to 2019 due to various factors such as ease-of-administration and higher efficacy.

In China, premixed insulin derivatives accounted for more than 50% of the market in 2012. Large population of type 1 diabetes patients and rising preference for insulin as diabetes treatment (both type 1 and type 2) are some of the factors contributing to the growth of the insulin market in China. Moreover, improving medical infrastructure, changing lifestyle, increased consumption of fast food and changing dietary habits are some of the factors expected to drive the insulin market in China.

Read the Current Market Status of Global and China Insulin at: http://www.transparencymarketresearch.com/insulin-market.html

The global insulin market is highly consolidated and dominated by few market players such as Eli Lilly and Company, Sanofi, and Novo Nordisk A/S. Moreover, these players account for more than 80% of the total insulin market in China. Domestic players such as Shanghai Fosun Pharmaceutical Co., Ltd. and Tonghua Dongbao hold a small share in the Chinese market.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.